NSAID vs Steroid in Trabeculectomy Wound Management

Last updated: October 15, 2020
Sponsor: Cindy Hutnik
Overall Status: Active - Not Recruiting

Phase

4

Condition

Glaucoma

Treatment

N/A

Clinical Study ID

NCT03751059
TWM
  • Ages > 18
  • All Genders

Study Summary

This study will examine the efficacy of steroid vs NSAID treatment in relation to trabeculectomy wound management. Eligible study participants will be randomized to receive either steroid or NSAID topical treatment one week post-trabeculectomy. Each group will dose with their assigned study treatment until three months post-trabeculectomy. Study participants will be followed for twelve months post-trabeculectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult patients over the age of 18 years

  • Uncontrolled open angle glaucoma

  • Scheduled to undergo stand-alone trabeculectomy

  • No previous incisional glaucoma surgery

  • No ocular surgery of any kind in prior 6 months

Exclusion

Exclusion Criteria:

  • steroids and/or NSAIDs contraindicated

  • poor corneal epithelial health

Study Design

Total Participants: 150
Study Start date:
November 01, 2020
Estimated Completion Date:
December 31, 2021